CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4/A Grant or award SVP, Bioservices acquired 62,500 shares (grant or award)
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- 8-K Event Other events
- DEF 14A Proxy Proxy Statement
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- 4 Open-market sale Director sold 35,000 shares at $5.83 ($204,050)
- 4 Open-market sale Director sold 10,000 shares at $5.73 ($57,300)
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- 4 Grant or award SVP, General Counsel, Corp Sec acquired 62,500 shares (grant or award)
- 4 Grant or award SVP, Products Business acquired 62,500 shares (grant or award)
- 4 Grant or award EVP, Chief Financial Officer acquired 146,888 shares (grant or award)
- 4 Grant or award SVP, R&D, CMO acquired 62,500 shares (grant or award)
- 4 Grant or award SVP, Bioservices acquired 62,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 282,500 shares (grant or award)
Page 8 of 87 · 1,733 filings